CompletedPhase 3NCT03672487
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Studying American trypanosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tulane University School of Public Health and Tropical Medicine
- Principal Investigator
- Pierre Buekens, MD, PhD, M.DTulane University
- Intervention
- Benznidazole(drug)
- Enrollment
- 87 enrolled
- Eligibility
- 13 years · FEMALE
- Timeline
- 2019 – 2025
Study locations (3)
- University of California at San Diego, San Diego, California, United States
- Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States
- Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina
Collaborators
Institute for Clinical Effectiveness and Health Policy · University of California, San Diego
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03672487 on ClinicalTrials.govOther trials for American trypanosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06632600A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.Novartis Pharmaceuticals
- ENROLLING BY INVITATIONNCT07033325University-Based Chagas Testing in Salta Province, ArgentinaMundo Sano Foundation
- RECRUITINGPHASE3NCT04897516Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseLaboratorio Elea Phoenix S.A.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04984265SBRT in Chagas Disease Ventricular TachycardiaUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT04024163Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas DiseaseInsud Pharma